Guardant Health, Inc. business relationships
Companies named in Guardant Health, Inc.’s 10-K filed 2026-02-19, and public companies whose annual reports name Guardant Health, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.5 / 10
- AI naming
- 76 / 100 Top 1% in its category
- Agent readiness
- 40 / 100
- AI adoption
- 0 / 100
Named in Guardant Health, Inc.’s annual report 2
“The MHLW additionally granted regulatory approval of the Guardant360 CDx liquid biopsy test as a companion diagnostic for identifying patients with metastatic NSCL cancer who may benefit from treatment with LUMAKRASTM (sotorasib), a KRAS G12C inhibitor developed and manufactured by Amgen.” SEC filing
“In the case of an alternative supplier for Illumina, for example, there can be no assurance that replacement sequencers and various associated reagents will be available or will meet our quality control and performance requirements for our laboratory operations.” SEC filing
Companies whose annual reports name Guardant Health, Inc. 1
“Based upon real-world evidence gathered in collaboration with Guardant Health, these patients have significant unmet medical needs.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.